Delivery Order SPE2DX22D0049-SPE2D825FB0KD
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,004.72 delivery order to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The award was competitively made with no set-aside designation, and...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,646.74 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,606.72 to AmerisourceBergen Drug Corp on August 23, 2025, with a completion deadline of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $12,185.65 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for an estimated value of $126,811.82 under a firm fixed-price contract structure. This non-competed delivery order, with an ultimate completion date of July 21, 2025, represents a procurement of pharmaceutical products and medical supplies to support federal military and healthcare operations. The work will be performed at the contractor's Corporate Office location...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $41,587.68 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract supporting federal medical procurement requirements. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $63,288.72 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FB0KDDelivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $66,408 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform all work at its Corporate Office location. The delivery order represents a child contract under the company's larger pharmaceutical supply relationship with the federal government. This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 pharmaceutical prime vendor agreement running through December 2026. The IDC authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, including medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The vendor serves as a critical supplier for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating significant capability in meeting large-scale federal medical procurement requirements through competitive delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.4k | 8/25/25 |